Public Employees Retirement Association of Colorado Sells 1,357 Shares of Colgate-Palmolive (NYSE:CL)

Public Employees Retirement Association of Colorado decreased its position in Colgate-Palmolive (NYSE:CL) by 1.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,476 shares of the company’s stock after selling 1,357 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Colgate-Palmolive were worth $10,429,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CL. Gryphon Financial Partners LLC bought a new position in Colgate-Palmolive in the 4th quarter valued at approximately $225,000. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Colgate-Palmolive by 6.1% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 184,902 shares of the company’s stock valued at $14,739,000 after purchasing an additional 10,589 shares in the last quarter. TCW Group Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $1,428,000. Team Hewins LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $374,000. Finally, Orion Portfolio Solutions LLC boosted its position in shares of Colgate-Palmolive by 13.2% during the fourth quarter. Orion Portfolio Solutions LLC now owns 50,526 shares of the company’s stock valued at $4,062,000 after buying an additional 5,888 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,490 shares of company stock valued at $4,486,063. Company insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on CL. Wells Fargo & Company cut Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective on the stock. in a research report on Monday, September 16th. TD Cowen increased their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Citigroup raised their target price on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, Evercore ISI upped their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $102.79.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $103.06 on Friday. The company has a market cap of $84.55 billion, a price-to-earnings ratio of 32.61, a PEG ratio of 3.72 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $109.30. The stock’s 50 day simple moving average is $102.71 and its two-hundred day simple moving average is $95.83. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the business posted $0.77 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.